Source comparison
Best AOD-9604 Dosage Metabolism 2026: Protocol Comparison
Low-Dose Baseline 100–200 mcg Once daily (AM) Fasted +15–25% glycerol vs baseline Preliminary metabolic screening, minimal intervention studies Establishes response threshold but suboptimal for sustained lipolysis Standard Research Dose 300–400 mcg +40–55% gly
This comparison does not assign a generated winner or score.
- Low-Dose Baseline
- 100–200 mcg
- Once daily (AM)
- Fasted
- +15–25% glycerol vs baseline
- Preliminary metabolic screening, minimal intervention studies
- Establishes response threshold but suboptimal for sustained lipolysis
- Standard Research Dose
- 300–400 mcg
- +40–55% glycerol vs baseline
- Primary metabolic endpoint studies, cost-effective protocols
- Optimal dose for receptor saturation. Further escalation adds no benefit
- Split-Dose Protocol
- 200 mcg × 2
- Twice daily (AM/PM)
- Mixed
- +35–45% glycerol vs baseline
- Studies requiring flexible timing, postprandial fat oxidation analysis
- Extends active window but doesn't increase peak effect vs single 300 mcg
- High-Dose Exploration
- 500–600 mcg
- +42–58% glycerol vs baseline
- Dose-ranging studies, safety assessments
- No additional lipolytic benefit vs 300 mcg. Receptor saturation is the ceiling